07 Jan 2001

Collomack® (Collomack® Lösung) - Deutschland

Updated: 07 Jan 2001


Hyperkeratosen, Hühneraugen, Schwielen, Warzen.

Collomack® Description, Presentation and Dosage

Collomack® Description

Collomack® Drug Class Description


Collomack® Drug Description

10 g enth.: Salicylsäure 2 g, Milchsäure 0,5 g, Polidocanol 0,2 g.

Collomack® Generic Name

Collomack® Lösung

Collomack® Presentation

Collomack® Presentation


Collomack® Manufacturer

Mack, Illert.

Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Collomack® Dosage

Collomack® Adult Dosage

Dibutylphthalat, Ethylcellulose, Aceton.

Collomack® Precautions, Reactions and Contraindications

Collomack® Special Precautions

Collomack® Adverse Reactions

Collomack® Adverse Reactions

S 5

Related Drugs - Dermatology

Back to top